Security researcher Lyra Rebane has devised a novel clickjacking attack that relies on Scalable Vector Graphics (SVG) and ...
ASH 2025 oral presentation on SENTI-202 in 20 Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) patients (18 response evaluable) shows high efficacy: 50% ORR and 42% CR/CRh (100% of CRs and 83% of ...
At the 2025 IEEE International Electron Devices Meeting (IEDM), research centre Imec is presenting breakthrough performance of p-type FETs with monolayer WSe 2 channels, and improved fab-compatible ...
1dOpinion
Designing For Digital Sovereignty: Leadership Lessons From Building AI-Native Infrastructure
Every nation and organization has the right to determine how its digital resources are governed, protected and shared.
RMAT designation indicates that SENTI-202 has the potential to address unmet medical needs for patients with Relapsed/Refractory (R/R) Acute ...
Investing.com -- Senti Biosciences (NASDAQ:SNTI) stock surged 29% after the company reported positive clinical trial results for its cancer therapy SENTI-202 and received FDA Regenerative Medicine ...
The participants First Spark is a deep tech venture capital fund investing in breakthrough technologies. Olcott said that he ...
The collaboration with A-LIGN strengthens LogicGate's position as a trusted partner for enterprises navigating increasingly complex regulatory landscapes. By integrating auditor expertise directly ...
Applied Materials' AI-fueled gains lift shares 56% this year, but export limits, rivals and valuation cloud the near-term outlook.
A team of Purdue students and faculty recommends these microelectronic-focused toys for developing STEM skills ...
The standing myth about AI is that it will put everyone out of work and leave the Marxian Reserve Army of Labor. The other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback